NexTGen: Next Generation T Cell Therapies for Childhood Cancers 2022 CANCER GRAND CHALLENGES AWARD, IN PARTNERSHIP WITH CANCER RESEARCH UK AND THE NATIONAL CANCER INSTITUTE Catherine Bollard, MBChB, MD, Children’s National Medical Center; Martin Pule, MD, University College London Read More
A Proof-of-Concept Clinical Trial of an Innovative New Therapy for Glioblastoma 2022 ASPIRE Award Douglas Hanahan, PhD, Ludwig Institute for Cancer Research Lausanne and the Swiss Federal Institute of Technology Lausanne (EPFL) and Andreas Hottinger, MD, PhD, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, Switzerland Read More
CRCbioscreen 2021 Program Related Investment Gerrit Meijer, MD, PhD, the Netherlands Cancer Institute Read More
Targeting Insulin to Improve Endometrial Cancer 2020 Partnership with The American Association for Cancer Research Marcus D. Goncalves, MD, PhD, Weill Cornell Medicine Read More
Overcoming BRAF/MEK Inhibition Resistance in Anaplastic Thyroid Carcinoma 2020 ASPIRE Award Jennifer Wang, MD (Principal); Mark Zafereo, MD; and Wenyi Wang, PhD, The University of Texas MD Anderson Cancer Center Read More
A Liquid Biopsy Test for the Early Detection of High-Risk Colorectal Adenomas 2020 ASPIRE Award Dan Landau, MD, PhD, Weill Cornell Medicine (Principal) and Claus Andersen, PhD, Aarhus University Read More
